Scientists from University College London have made a groundbreaking discovery that could slow the progression of Huntington’s disease. A new gene therapy, AMT-130, shows promising results in clinical trials, potentially changing lives forever.
Infection rates from drug-resistant 'nightmare bacteria' have surged nearly 70% from 2019 to 2023, driven by the NDM gene. Experts warn of potential community spread and increasing healthcare challenges.
Menopause can bring disruptive symptoms, but hormone therapy offers relief. Experts discuss its benefits and risks, urging women to make informed decisions about their treatment options.
Discover the multitude of hair loss treatments available for women and how to effectively navigate them. From telehealth services to traditional remedies, find out what works best for you!
ABC News anchor Linsey Davis shares her years-long struggle with uterine fibroids, shedding light on her diagnosis, treatment options, and the importance of raising awareness about this common condition among women.
In a surprising health announcement, President Trump has been diagnosed with chronic venous insufficiency (CVI). This condition, while common, raises questions about his health and treatment options. Learn more about CVI and its implications.
A groundbreaking study reveals that combining Trodelvy and Keytruda reduces tumor progression risk by over a third in aggressive breast cancer cases, paving the way for new treatment options.
A groundbreaking blood test cleared by the FDA offers a new way to diagnose Alzheimer's disease, improving accuracy and accessibility for millions. Experts believe this innovation will enhance patient care and early intervention.
In a stunning revelation, former President Joe Biden's office confirmed his prostate cancer diagnosis, raising questions about the timing and implications for his 2024 campaign. Experts weigh in on the risks and treatment options.
The FDA has approved the first blood test for Alzheimer's, allowing for earlier diagnosis and treatment with existing drugs. This groundbreaking development could significantly impact millions facing cognitive decline.
